Baricitinib plus remdesivir shows promise for treating COVID-19
News: Latest | Digests | Channels | Categories | Gallery
Posted on: December 11, 2020
Category: Medications
Baricitinib plus remdesivir shows promise for treating COVID-19
The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results published in the New England Journal of Medicine. The study was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Welcome to the healthcare-only HIPAA - GDPR compliant cloud. Exclusively hosted on a HPC environment!
Learn more or start today by choosing your secure HIPAA - GDPR compliant server's Operating System bellow and pick the package that's best for you.
BIPmd makes it simple to launch in the cloud and scale up as you grow – whether you’re running one virtual machine, thousand or more.
Looking for a custom solution?
Our technicians can provide you with the best custom-made solutionss on the market, no matter whether you're a small business or large enterprise.
Get in touch